Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours
Authors:
- Logan C. WalkerLWLogan C. Walker
- kConFab InvestigatorsKIkConFab Investigators
- Lutz KrauseLKLutz Krause
- Amanda B. SpurdleASAmanda B. Spurdle
- Nic WaddellNic Waddell
Open Access
- 21 March 2012
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 134 (3) , 1005-1011
Abstract
A characteristic of sporadic and familial breast tumours is genomic instability, resulting from either inherited mutations in genes that control genome integrity or mutations that are acquired in somatic cells during development. It is well established that abnormal chromosome number and structural changes to chromosomes play an important role in the cause and progression of breast cancer. Familial BRCA1 breast tumours are characterised by basal-like phenotype and high-histological grade which are typically associated with increased genomic instability. Consistent with previous studies, the genomes with the greatest number of base pairs covered by copy number change were typically found in basal-like and/or high-histological grade breast tumours within our cohort. Moreover, we show that luminal A tumours that are high grade had significantly less copy number variant (CNV) coverage than the more clinically aggressive high-grade luminal B tumours, suggesting that chromosomal instability rather than cellular differentiation contributes to the aggressive nature of luminal B tumours. It has previously been proposed that germline CNVs may contribute to somatically acquired chromosome changes in the tumour, but this is the first study to address this idea in breast cancer. By comparing germline CNVs and tumour-specific CNVs in matched breast tumour and normal tissue using data from the Illumina Human CNV370 duo beadarray, we provide evidence that germline CNVs do not tend to act as a foundation on which larger chromosome copy number aberrations develop in tumour cells. Further studies are required with increased sequence resolution that will detect smaller CNVs and define CNV breakpoints to comprehensively assess the relationship between inherited genomic variation and genome evolution in breast cancer.Keywords
This publication has 23 references indexed in Scilit:
- Insight into the heterogeneity of breast cancer through next-generation sequencingJournal of Clinical Investigation, 2011
- Heterogeneity in breast cancerJournal of Clinical Investigation, 2011
- Complex landscapes of somatic rearrangement in human breast cancer genomesNature, 2009
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndromeProceedings of the National Academy of Sciences, 2008
- SNP Arrays in Heterogeneous Tissue: Highly Accurate Collection of Both Germline and Somatic Genetic Information from Unpaired Single Tumor SamplesThe American Journal of Human Genetics, 2008
- Basal-like breast cancer and the BRCA1 phenotypeOncogene, 2006
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991